Efficacy and Safety of Longyizhengqi Granule in Treatment of Mild COVID-19 Patients Caused by SARS-CoV-2 Omicron Variant: A Prospective Study

PURPOSE: This study aimed to evaluate the clinical efficacy of Longyizhengqi granule, a traditional Chinese medicine, in patients with mild COVID-19. PATIENTS AND METHODS: We conducted a prospective study including mild COVID-19 participants conducted at Mobile Cabin Hospital in Shanghai, China. Par...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Miao, Shi, Jin, Zhang, Kepei, Hong, Jie, Peng, Xinwei, Tian, Yu, Lu, Wei, Li, Ke, Wang, Zengliang, Li, Feng, Zhang, Zhijie, Mei, Guojiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10038206/
https://www.ncbi.nlm.nih.gov/pubmed/36969939
http://dx.doi.org/10.2147/IDR.S389883

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10038206/
https://www.ncbi.nlm.nih.gov/pubmed/36969939
http://dx.doi.org/10.2147/IDR.S389883

Ejemplares similares